| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2024 ( Subtotal = $27,671,878 ) (Continued on the next page) |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI116917 | Mechanisms of the Development and Maintenance of Salmonella Gallbladder Carriage | 000 | 10 | NIH | 3/28/2024 | $548,318 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA278995 | A New Paradigm to Prevent and Treat Micrometastases | 000 | 1 | NIH | 1/31/2024 | $504,838 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS134923 | Uncovering mechanisms and developing novel therapeutic strategies for TBCD-related developmental and epileptic encephalopathy | 000 | 1 | NIH | 1/25/2024 | $641,082 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AI183689 | Adaptive Features of In-Utero Natural Killer Cell Responses to Congenital Cytomegalovirus Infection | 001 | 1 | NIH | 2/7/2024 | $0 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AI183689 | Adaptive Features of In-Utero Natural Killer Cell Responses to Congenital Cytomegalovirus Infection | 000 | 1 | NIH | 1/26/2024 | $210,600 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F32HL170581 | A Dynamic and Three-Dimensional Human Model of Hypoplastic Left Heart Syndrome to Probe Compromised Cardiomyocyte Proliferation | 000 | 1 | NIH | 4/15/2024 | $71,792 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21MD019075 | Feasibility and Usability of a Spanish-Transcreated Pediatric Post-Transplant Adherence App (BMT4me) | 000 | 2 | NIH | 2/23/2024 | $214,077 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MH130437 | Neurodevelopmental Mechanisms Underlying the Onset of Depression among At-Risk Youth: The Role of Dysregulation in the Negative Valence System | 000 | 2 | NIH | 3/28/2024 | $659,186 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | F31HL168950 | Computational methods to elucidate the role of long non-coding RNA in Congenital Heart Disease | 000 | 2 | NIH | 4/2/2024 | $39,298 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | U01DK135015 | Identify risk factors for type 2 diabetes in adolescents | 000 | 2 | NIH | 3/8/2024 | $698,928 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI175800 | Role of antibodies in hepatitis E virus infection | 000 | 2 | NIH | 3/21/2024 | $822,317 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS129784 | Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution | 002 | 2 | NIH | 4/25/2024 | $40,842 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS129784 | Deciphering brain mosaicism in drug-resistant epilepsy at cellular resolution | 001 | 2 | NIH | 12/25/2023 | $525,130 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI175004 | Decipher and target GABA metabolism and GABA receptor-mediated signaling in autoimmune diseases | 000 | 2 | NIH | 1/18/2024 | $450,048 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI174180 | Mechanism for hepatitis E virus exit from polarized hepatocytes | 000 | 2 | NIH | 1/18/2024 | $466,223 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI171027 | Pre-Existing Atopy and Respiratory Viral Infections | 000 | 2 | NIH | 1/17/2024 | $649,009 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL165124 | The Role of Notch Signaling in Type 2 Diabetic Coronary Microvascular Disease | 000 | 2 | NIH | 2/1/2024 | $547,566 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL161338 | 1/2 percutaneous intervention versus observational trial of arterial ductus in lower gestational age infants (PIVOTAL) | 001 | 3 | NIH | 2/1/2024 | $643,579 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AI169339 | Defining a novel mechanism of adhesion present in multiple infective endocarditis causing species | 000 | 2 | NIH | 12/5/2023 | $201,960 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | H3348997 | EMSC Partnership Grants | 00 | 2 | HRSA | 3/21/2024 | $83,352 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DE031756 | Regulation and Manipulation of Oral Type III Interferon Responses by Porphyromonas gingivalis | 000 | 2 | NIH | 1/2/2024 | $375,453 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R21AI171928 | A sequence-independent approach for attenuating hepaciviruses | 000 | 2 | NIH | 10/24/2023 | $210,600 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HD107280 | Poly-Matching Causal Inference for Assessing Multiple Acute Medical Managements of Pediatric Traumatic Brain Injuries | 000 | 2 | NIH | 1/17/2024 | $493,665 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS126352 | Molecular Mechanisms of Dystrophin Expression in Ameliorated Phenotypes | 001 | 2 | NIH | 4/25/2024 | $31,806 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01NS126352 | Molecular Mechanisms of Dystrophin Expression in Ameliorated Phenotypes | 000 | 2 | NIH | 1/12/2024 | $408,932 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL163065 | A preclinical study evaluating and comparing the efficacy of tissue engineered vascular grafts to polytetrafluoroethylene grafts - DIVERSITY SUPP VILLARREAL | 000 | 2 | NIH | 12/7/2023 | $51,566 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL163065 | A preclinical study evaluating and comparing the efficacy of tissue engineered vascular grafts to polytetrafluoroethylene grafts - DIVERSITY SUPP VILLARREAL | 001 | 2 | NIH | 12/21/2023 | -$51,566 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL163065 | A preclinical study evaluating and comparing the efficacy of tissue engineered vascular grafts to polytetrafluoroethylene grafts - DIVERSITY SUPP VILLARREAL | 001 | 2 | NIH | 12/21/2023 | $51,566 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | K08NS119878 | Reversal of Immunoparalysis Following Traumatic Brain Injury and Systemic Hemorrhage in a Juvenile Rat Model | 000 | 3 | NIH | 4/5/2024 | $187,635 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01MD016064 | Racial/ethnic and geographic differences in pediatric tonsillectomy use: a multilevel investigation | 000 | 3 | NIH | 1/5/2024 | $409,822 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157208 | Transfusion and Organ Dysfunction in Pediatric Septic Shock (TROPICS) study | 000 | 3 | NIH | 3/13/2024 | $625,315 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01DA052580 | Evaluating the impact of fentanyl test strip use among rural and urban populations | 000 | 4 | NIH | 4/23/2024 | $667,241 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157491 | Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | 001 | 4 | NIH | 3/4/2024 | $77,902 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL157491 | Elucidating the Molecular Mechanisms Underlying LYST-mediated Tissue Engineered Vascular Graft Stenosis | 000 | 4 | NIH | 3/1/2024 | $577,406 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01AI151175 | Immune correlates of protection against hepacivirus persistence. | 000 | 4 | NIH | 3/7/2024 | $553,345 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | UH3HL148693 | A Study Evaluating the Safety and Efficacy of Second-Generation Tissue Engineered Vascular Grafts (TEVG2) | 000 | 4 | NIH | 2/12/2024 | $533,894 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 001 | 4 | NIH | 1/24/2024 | $114,128 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 001 | 4 | NIH | 4/17/2024 | $34,546 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 000 | 4 | NIH | 1/19/2024 | $385,000 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA248103 | Psychosocial Risk in Young Survivors of Early Onset Pediatric Cancer: The Role of Physical and Neurocognitive Late Effects | 000 | 4 | NIH | 2/5/2024 | $621,816 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 003 | 4 | NIH | 2/7/2024 | -$77,578 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155282 | An integrated human stem cell model for elucidating myocardial-endocardial interactions in cardiac development and disease | 002 | 4 | NIH | 1/25/2024 | $77,578 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA247941 | Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy | 001 | 4 | NIH | 4/18/2024 | $23,992 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01CA247941 | Modulation of asparagine bioavailability and stress response signaling to enhance T cell robustness and maximize immunotherapy | 000 | 4 | NIH | 1/29/2024 | $431,859 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155095 | Airway Structural Cells and Corticosteroid Resistance in Asthma | 001 | 4 | NIH | 12/1/2023 | $62,586 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | R01HL155095 | Airway Structural Cells and Corticosteroid Resistance in Asthma | 000 | 4 | NIH | 11/22/2023 | $408,885 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 02 | 5 | CMS | 2/15/2024 | $0 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 01 | 5 | CMS | 1/18/2024 | $0 |
| | 2024 | 2024 | RESEARCH INSTITUTE AT NATIONWIDE CHILDREN'S HOSPITAL | 700 CHILDRENS DR | COLUMBUS | OH | 43205-2664 | FRANKLIN | USA | 2B2CMS331798 | Integrated Care for Kids (InCK) | 00 | 5 | CMS | 12/15/2023 | $1,925,201 |
|
